Schrodinger Inc (SDGR)
Cash conversion cycle
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | — | — | — | — | — |
| Days of sales outstanding (DSO) | days | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — |
| Cash conversion cycle | days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= — + — – —
= 0.00
The cash conversion cycle of Schrodinger Inc has remained consistently at 0.00 days from December 31, 2020, to December 31, 2024. This indicates that the company is efficiently managing its cash flow, operating cycle, and working capital. With a cash conversion cycle of zero days, Schrodinger Inc is able to effectively turn its inventory into cash without delays and efficiently collect payments from customers, showcasing strong financial management and operational efficiency.
Peer comparison
Dec 31, 2024
Company name
Symbol
Cash conversion cycle
Schrodinger Inc
SDGR
0.00
Abbott Laboratories
ABT
120.86
AbbVie Inc
ABBV
90.28
ACADIA Pharmaceuticals Inc
ACAD
97.89
Alkermes Plc
ALKS
146.34
Amphastar P
AMPH
193.56
ANI Pharmaceuticals Inc
ANIP
199.53
Arcus Biosciences Inc
RCUS
-36.73
Biomarin Pharmaceutical Inc
BMRN
860.14
Bristol-Myers Squibb Company
BMY
69.21
Catalyst Pharmaceuticals Inc
CPRX
103.60